FibroGen Inc at Jefferies Healthcare Conference (Virtual) Transcript
Well, good morning, everyone, and welcome to another great session here on the last day of our 2021 Jefferies Virtual Global Healthcare Conference. We've had a great week, obviously, this week. And one of the teams I'm obviously looking forward to meeting with here today is FibroGen. We have the CEO Enrique Conterno here with us. And obviously, a lot going on at the Company and obviously gearing up for some important decisions and important events this year.
I would just love to start off, Enrique, maybe you could give some opening comments about where FibroGen stands today with roxa. Obviously, both the US and the European developments kind of going on simultaneously. And that would be great as you prepare, obviously, for an AdCom and a whole lot of different scenarios. So that would be great to turn it over to you.
Thank you, Michael, and great to be here, be able to chat with you once again. We continue to be enthusiastic and excited about the opportunity of roxadustat to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |